Procaps S.A. has completed a private placement of senior notes
Procaps S.A. has raised funds to refinance existing debt with new institutional investors.
Procaps is a leading integrated international healthcare and pharmaceutical company that develops, manufactures and markets over-the-counter and prescription drugs, nutritional supplements and high-potency clinical solutions. Procaps has a product reach in 50 markets and has strategically positioned itself to achieve its M&A initiative and expand new product categories in the B2B and B2C segments.
Oaklins’ team in Chile acted as the sole financial advisor to Procaps S.A. in the private placement of senior unsecured fixed-rate notes for an aggregate principal amount of US$115 million.
Contáctese con el equipo de la transacción
Transacciones relacionadas
Foreman Capital has raised financing for the acquisition of Rijcken Groep
Foreman Capital, a Netherlands-based private equity firm, has secured debt financing for the acquisition of international food wholesaler Rijcken Groep. The financing package, provided through a club deal by Rabobank and ING, is designed to support Rijcken Groep’s organic growth as well as its planned buy-and-build strategy.
Aprenda másLeika Medical Equipments Ltd. has been acquired by Angus Capital
The shareholders of Leika Medical Equipments Ltd. have sold the company to Angus Capital.
Aprenda másPhen’X Technologies has sold a majority stake to Ciclad
The shareholders of Phen’X Technologies have completed a primary majority LBO with private equity fund Ciclad.
Aprenda más